Article info
Cancer genetics
Original article
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)
- Correspondence to Dr Eric Hahnen, Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne 50931, Germany; eric.hahnen{at}uk-koeln.de
Citation
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)
Publication history
- Received December 7, 2018
- Revised February 26, 2019
- Accepted March 14, 2019
- First published April 12, 2019.
Online issue publication
August 21, 2019
Article Versions
- Previous version (12 April 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.